NVOS Novo Integrated Sciences Inc

USD 0.53 0.01 1.941748
Icon

Novo Integrated Sciences Inc (NVOS) Stock Analysis and Price Targets

COMMON STOCK | Medical Care Facilities | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.525

+0.01 (+1.94)%

USD 9.06M

0.54M

N/A

N/A

Icon

NVOS

Novo Integrated Sciences Inc (USD)
COMMON STOCK | NSD
USD 0.53
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 9.06M

N/A

USD 0.53

Novo Integrated Sciences Inc (NVOS) Stock Forecast

N/A

Based on the Novo Integrated Sciences Inc stock forecast from 0 analysts, the average analyst target price for Novo Integrated Sciences Inc is not available over the next 12 months. Novo Integrated Sciences Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Novo Integrated Sciences Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Novo Integrated Sciences Inc’s stock price was USD 0.525. Novo Integrated Sciences Inc’s stock price has changed by +2.96% over the past week, +2.90% over the past month and -50.93% over the last year.

No recent analyst target price found for Novo Integrated Sciences Inc
No recent average analyst rating found for Novo Integrated Sciences Inc

Company Overview Novo Integrated Sciences Inc

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic ca...Read More

11120 NE 2nd Street, Bellevue, WA, United States, 98004

127

August

USD

USA

Adjusted Closing Price for Novo Integrated Sciences Inc (NVOS)

Loading...

Unadjusted Closing Price for Novo Integrated Sciences Inc (NVOS)

Loading...

Share Trading Volume for Novo Integrated Sciences Inc Shares

Loading...

Compare Performance of Novo Integrated Sciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NVOS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Novo Integrated Sciences Inc (Sector: Medical Care Facilities )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ENSG
The Ensign Group Inc +0.02 (+0.02%) USD7.02B 33.92 23.65

ETFs Containing NVOS

Symbol Name NVOS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Novo Integrated Sciences Inc (NVOS) Stock

Stock Target Advisor's fundamental analysis for Novo Integrated Sciences Inc's stock is Bearish.

Unfortunately we do not have enough data on NVOS's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on NVOS's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on NVOS's stock to indicate if its overvalued.

The last closing price of NVOS's stock was USD 0.53.

The most recent market capitalization for NVOS is USD 9.06M.

Unfortunately we do not have enough analyst data on NVOS's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Novo Integrated Sciences Inc's stock.

As per our most recent records Novo Integrated Sciences Inc has 127 Employees.

Novo Integrated Sciences Inc's registered address is 11120 NE 2nd Street, Bellevue, WA, United States, 98004. You can get more information about it from Novo Integrated Sciences Inc's website at https://www.novointegrated.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...